Charles KA[au] - Search Results

Year	Number of Results
1984	1
2004	1
2005	1
2006	3
2008	3
2009	2
2010	2
2011	4
2012	2
2013	3
2014	1
2015	1
2016	1
2017	1
2018	2
2019	2
2020	1
2021	1
2023	2
2024	1

1

Cancer-related inflammation and treatment effectiveness.

Diakos CI, Charles KA, McMillan DC, Clarke SJ. Diakos CI, et al. Among authors: charles ka. Lancet Oncol. 2014 Oct;15(11):e493-503. doi: 10.1016/S1470-2045(14)70263-3. Lancet Oncol. 2014. PMID: 25281468 Review.

2

Inflammation and cancer: causes and consequences.

Moore MM, Chua W, Charles KA, Clarke SJ. Moore MM, et al. Among authors: charles ka. Clin Pharmacol Ther. 2010 Apr;87(4):504-8. doi: 10.1038/clpt.2009.254. Epub 2010 Feb 10. Clin Pharmacol Ther. 2010. PMID: 20147899 Review.

3

Shinko D, Diakos CI, Clarke SJ, Charles KA. Shinko D, et al. Among authors: charles ka. Clin Pharmacol Ther. 2017 Oct;102(4):599-610. doi: 10.1002/cpt.789. Epub 2017 Aug 24. Clin Pharmacol Ther. 2017. PMID: 28699186 Review.

4

Tumour necrosis factor-alpha as a tumour promoter.

Szlosarek P, Charles KA, Balkwill FR. Szlosarek P, et al. Among authors: charles ka. Eur J Cancer. 2006 Apr;42(6):745-50. doi: 10.1016/j.ejca.2006.01.012. Epub 2006 Mar 6. Eur J Cancer. 2006. PMID: 16517151 Review.

5

The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.

Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. Guthrie GJ, et al. Among authors: charles ka. Crit Rev Oncol Hematol. 2013 Oct;88(1):218-30. doi: 10.1016/j.critrevonc.2013.03.010. Epub 2013 Apr 17. Crit Rev Oncol Hematol. 2013. PMID: 23602134 Review.

6

A Scoping Review of Pharmacogenomic Educational Interventions to Improve Knowledge and Confidence.

Soueid R, Michael TJF, Cairns R, Charles KA, Stocker SL. Soueid R, et al. Among authors: charles ka. Am J Pharm Educ. 2024 Mar;88(3):100668. doi: 10.1016/j.ajpe.2024.100668. Epub 2024 Feb 6. Am J Pharm Educ. 2024. PMID: 38331197 Free article. Review.

7

Smoldering and polarized inflammation in the initiation and promotion of malignant disease.

Balkwill F, Charles KA, Mantovani A. Balkwill F, et al. Among authors: charles ka. Cancer Cell. 2005 Mar;7(3):211-7. doi: 10.1016/j.ccr.2005.02.013. Cancer Cell. 2005. PMID: 15766659 Free article. Review. No abstract available.

8

Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer.

Chua W, Kho PS, Moore MM, Charles KA, Clarke SJ. Chua W, et al. Among authors: charles ka. Crit Rev Oncol Hematol. 2011 Sep;79(3):224-50. doi: 10.1016/j.critrevonc.2010.07.012. Epub 2010 Aug 16. Crit Rev Oncol Hematol. 2011. PMID: 20719530 Review.

9

Staining of Phosphorylated Signalling Markers Protocol for Mass Cytometry.

Shinko D, Ashhurst TM, McGuire HM, Charles KA. Shinko D, et al. Among authors: charles ka. Methods Mol Biol. 2019;1989:139-146. doi: 10.1007/978-1-4939-9454-0_10. Methods Mol Biol. 2019. PMID: 31077104

10

Quantification of short-chain fatty acids in human stool samples by LC-MS/MS following derivatization with aniline analogues.

McKay MJ, Castaneda M, Catania S, Charles KA, Shanahan E, Clarke SJ, Engel A, Varelis P, Molloy MP. McKay MJ, et al. Among authors: charles ka. J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Feb 15;1217:123618. doi: 10.1016/j.jchromb.2023.123618. Epub 2023 Jan 27. J Chromatogr B Analyt Technol Biomed Life Sci. 2023. PMID: 36731355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year